Inactive Instrument

Press Releases Genkyotex CBOE EUROPE EQUITIES

Equities

FR0011790542

End-of-day quote CBOE EUROPE EQUITIES Other stock markets
- ^EUR	-

2021	Calliditas Therapeutics : Acquires Remaining Stake in Genkyotex	MT
2021	Genkyotex SA(ENXTPA:GKTX) dropped from CAC AllShares Index	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Calliditas Therapeutics : announces acquisition of remaining Genkyotex minority shares	07/10/21	AQ
Genkyotex : provides business update and reports cash position at March 31, 2021	13/05/21	PU
Calliditas Therapeutics : Year-End Report, 2020	19/02/21	AQ
Calliditas Therapeutics : Year-End Report, 2020	18/02/21	AQ
Genkyotex : provides Q4 business update and reports cash position	27/01/21	PU
Genkyotex : announces update for near term clinical development plan for setanaxib	25/01/21	AQ
Calliditas Therapeutics AB : - Positive Phase 1 results in high-dose setanaxib trial	19/01/21	AQ
Calliditas Therapeutics : Positive Phase 1 results in high-dose setanaxib trial	18/01/21	AQ
Calliditas Therapeutics : announces final outcome of simplified mandatory offer to the shareholders of Genkyotex	16/12/20	AQ
Genkyotex :'s setanaxib granted Orphan Drug Designation by the European Commission for the treatment of PBC	09/12/20	AQ
Calliditas Therapeutics : Interim Report Q3, 2020	13/11/20	AQ
Calliditas Therapeutics : Interim Report Q3, 2020	12/11/20	AQ
Genkyotex : announces the closing of the acquisition by Calliditas Therapeutics of a controlling interest in Genkyotex :	04/11/20	AQ
Genkyotex : Calliditas closes acquisition of a controlling interest in Genkyotex SA	04/11/20	AQ
Calliditas Therapeutics : closes acquisition of a controlling interest in Genkyotex SA	03/11/20	AQ
Genkyotex : provides business update and reports cash position at September 30, 2020	23/10/20	AQ
Genkyotex : provides business update and reports cash position at September 30, 2020	22/10/20	PU
Genkyotex :'s setanaxib granted Orphan Drug Designation by the US FDA for the treatment of PBC	21/10/20	AQ
Genkyotex : setanaxib granted Orphan Drug Designation by the US FDA for the treatment of PBC	20/10/20	PU
Genkyotex : announces first-half 2020 results and business update	17/09/20	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Genkyotex CBOE EUROPE EQUITIES

Equities

FR0011790542

Press Releases

Filters